Clinical characteristics and outcomes of non-compaction cardiomyopathy
| Author | Chin2 | Ichida15 | Oechslin4 | Murphy20 | Lofiego17 | Aras19 | Stanton21 | Greutmann18 |
|---|---|---|---|---|---|---|---|---|
| Patients (N) | 8 | 27 | 34 | 45 | 65 | 67 | 30 | 132 |
| Type of population | Paediatric | Paediatric | Adult | Adult | Adult | Adult | Adult | >14 years |
| Family history (%) | 50 | 44 | 18 | 51* | 31 | 33 | – | 23 |
| Follow-up | ≤5 years | ≤17 years | Mean 44 months | Mean 46 months | Mean 46 months | Mean 30 months | Mean 2.5 years | Mean 2.7 years |
| Heart failure (%) | 63 | 30 | 68 | 67 | 34 | 34 | – | 13 |
| Embolic events (%) | 38 | 0 | 21 | 4 | 5 | 9 | 0 | 4 |
| Ventricular tachycardia (%) | 38 | 0 | 41 | 20† | 6 | 36 | 27† | 4 |
| Cardiovascular death or transplantation (%) | 0 | 11 | 47 | 2 | 24 | 15 | 10 | 23 |
| Sudden death (%) | 13 | 0 | 18 | 2 | 5 | 9 | 10 | 9 |
*Non-compaction and dilated cardiomyopathy.
†Non-sustained ventricular tachycardia.